Falcone Colomba相关文献与解析，生知库 | 链接生命科学的每一步

Anti-diabetic agents and heart health: how to use new diabetes medications in a global strategy for the prevention of cardiovascular complications in type 2 diabetes

抗糖尿病药物与心脏健康：如何在预防2型糖尿病心血管并发症的全球战略中使用新型糖尿病药物

期刊:Annals of Translational Medicine

影响因子:

doi:10.21037/atm.2018.03.30

Gazzaruso, Carmine; Coppola, Adriana; Montalcini, Tiziana; Falcone, Colomba

Erectile dysfunction as a predictor of asymptomatic coronary artery disease in elderly men with type 2 diabetes

勃起功能障碍作为2型糖尿病老年男性无症状冠状动脉疾病的预测指标

期刊:Journal of Geriatric Cardiology

影响因子:2.6

doi:10.11909/j.issn.1671-5411.2016.06.011

Gazzaruso, Carmine; Coppola, Adriana; Pujia, Arturo; Falcone, Colomba; Collaviti, Silvia; Fodaro, Mariangela; Gallotti, Pietro; Solerte, Sebastiano B; Giustina, Andrea; Pelissero, Gabriele; Luzi, Livio; Montalcini, Tiziana

Soluble RAGE plasma levels in patients with coronary artery disease and peripheral artery disease.

冠状动脉疾病和外周动脉疾病患者的血浆可溶性RAGE水平

期刊:Scientific World Journal

影响因子:

doi:10.1155/2013/584504

Falcone Colomba, Bozzini Sara, Guasti Luigina, D'Angelo Angela, Capettini Anna Clizia, Paganini Edoardo Maria, Falcone Rossana, Moia Roberto, Gazzaruso Carmine, Pelissero Gabriele

其它

发表日期：2013

文献求助收藏

Microalbuminuria and sRAGE in high-risk hypertensive patients treated with nifedipine/telmisartan combination treatment: a substudy of TALENT.

硝苯地平/替米沙坦联合治疗对高危高血压患者的微量白蛋白尿和 sRAGE 的影响：TALENT 的一项子研究

期刊:Mediators of Inflammation

影响因子:4.2

doi:10.1155/2012/874149

Falcone Colomba, Buzzi Maria Paola, Bozzini Sara, Boiocchi Chiara, D'Angelo Angela, Schirinzi Sandra, Esposito Ciro, Torreggiani Massimo, Choi Jasmine, Ochan Kilama Michael, Mancia Giuseppe

Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects

载脂蛋白(a)大小多态性与超重人群冠心病的关系

期刊:BMC Cardiovascular Disorders

影响因子:2.3

doi:10.1186/1471-2261-3-12

Emanuele, Enzo; Peros, Emmanouil; Minoretti, Piercarlo; Falcone, Colomba; D'Angelo, Angela; Montagna, Lorenza; Geroldi, Diego

Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism

2型糖尿病患者的无症状冠状动脉疾病：脂蛋白(a)、同型半胱氨酸和载脂蛋白(a)多态性的作用

期刊:Cardiovascular Diabetology

影响因子:10.6

doi:10.1186/1475-2840-1-5

Gazzaruso, Carmine; Garzaniti, Adriana; Giordanetti, Stefano; Falcone, Colomba; Fratino, Pietro

Cardiovascular characteristics of chronic fatigue syndrome

慢性疲劳综合征的心血管特征

Anti-diabetic agents and heart health: how to use new diabetes medications in a global strategy for the prevention of cardiovascular complications in type 2 diabetes

抗糖尿病药物与心脏健康：如何在预防2型糖尿病心血管并发症的全球战略中使用新型糖尿病药物

Erectile dysfunction as a predictor of asymptomatic coronary artery disease in elderly men with type 2 diabetes

勃起功能障碍作为2型糖尿病老年男性无症状冠状动脉疾病的预测指标

Soluble RAGE plasma levels in patients with coronary artery disease and peripheral artery disease.

冠状动脉疾病和外周动脉疾病患者的血浆可溶性RAGE水平

Microalbuminuria and sRAGE in high-risk hypertensive patients treated with nifedipine/telmisartan combination treatment: a substudy of TALENT.

硝苯地平/替米沙坦联合治疗对高危高血压患者的微量白蛋白尿和 sRAGE 的影响：TALENT 的一项子研究

Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects

载脂蛋白(a)大小多态性与超重人群冠心病的关系

Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism

2型糖尿病患者的无症状冠状动脉疾病：脂蛋白(a)、同型半胱氨酸和载脂蛋白(a)多态性的作用